-
1
-
-
84954400636
-
-
CA Cancer J. Clin.
-
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7-30 (2016).
-
(2016)
Cancer Statistics 2016
, vol.66
, pp. 7-30
-
-
Siegel, R.L.1
Miller, K.D.2
Jemal A3
-
2
-
-
84994539749
-
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: A population-based, observational study
-
Wallington, M. et al. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncol. 17, 1203-1216 (2016).
-
(2016)
Lancet Oncol.
, vol.17
, pp. 1203-1216
-
-
Wallington, M.1
-
3
-
-
84856796565
-
Preparing for precision medicine
-
Mirnezami, R., Nicholson, J. & Darzi, A. Preparing for precision medicine. N. Engl. J. Med. 366, 489-491 (2012).
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 489-491
-
-
Mirnezami, R.1
Nicholson, J.2
Darzi, A.3
-
4
-
-
75549083303
-
Tumor heterogeneity: Causes and consequences
-
Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105-117 (2010).
-
(2010)
Biochim. Biophys. Acta
, vol.1805
, pp. 105-117
-
-
Marusyk, A.1
Polyak, K.2
-
5
-
-
84860214990
-
Intra-tumour heterogeneity: A looking glass for cancer?
-
Marusyk, A., Almendro, V. & Polyak, K. Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer 12, 323-334 (2012).
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 323-334
-
-
Marusyk, A.1
Almendro, V.2
Polyak, K.3
-
6
-
-
84886719809
-
Cancer drugs in the United States: Justum Pretium-the just price
-
Kantarjian, H. M., Fojo, T., Mathisen, M. & Zwelling, L. A. Cancer drugs in the United States: Justum Pretium-the just price. J. Clin. Oncol. 31, 3600-3604 (2013).
-
(2013)
J. Clin. Oncol.
, vol.31
, pp. 3600-3604
-
-
Kantarjian, H.M.1
Fojo, T.2
Mathisen, M.3
Zwelling, L.A.4
-
7
-
-
84876678621
-
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma
-
Weber, J. S. et al. Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer 119, 1675-1682 (2013).
-
(2013)
Cancer
, vol.119
, pp. 1675-1682
-
-
Weber, J.S.1
-
8
-
-
84971231413
-
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
-
Welsh, S. J., Rizos, H., Scolyer, R. A. & Long, G. V. Resistance to combination BRAF and MEK inhibition in metastatic melanoma: where to next? Eur. J. Cancer 62, 76-85 (2016).
-
(2016)
Eur. J. Cancer
, vol.62
, pp. 76-85
-
-
Welsh, S.J.1
Rizos, H.2
Scolyer, R.A.3
Long, G.V.4
-
9
-
-
33750719994
-
Global systems biology, personalized medicine and molecular epidemiology
-
Nicholson, J. K. Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2, 52 (2006).
-
(2006)
Mol. Syst. Biol.
, vol.2
, pp. 52
-
-
Nicholson, J.K.1
-
10
-
-
84958841613
-
The gut microbiota and host health: A new clinical frontier
-
Marchesi, J. R. et al. The gut microbiota and host health: a new clinical frontier. Gut 65, 330-339 (2016).
-
(2016)
Gut
, vol.65
, pp. 330-339
-
-
Marchesi, J.R.1
-
11
-
-
84871454511
-
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk
-
Holmes, E., Li, J. V., Marchesi, J. R. & Nicholson, J. K. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16, 559-564 (2012).
-
(2012)
Cell Metab.
, vol.16
, pp. 559-564
-
-
Holmes, E.1
Li, J.V.2
Marchesi, J.R.3
Nicholson, J.K.4
-
12
-
-
84861978076
-
Host-gut microbiota metabolic interactions
-
Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262-1267 (2012).
-
(2012)
Science
, vol.336
, pp. 1262-1267
-
-
Nicholson, J.K.1
-
13
-
-
17844404232
-
Gut microorganisms, mammalian metabolism and personalized health care
-
Nicholson, J. K., Holmes, E. & Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431-438 (2005).
-
(2005)
Nat. Rev. Microbiol.
, vol.3
, pp. 431-438
-
-
Nicholson, J.K.1
Holmes, E.2
Wilson, I.D.3
-
14
-
-
84954379199
-
The influence of gut microbiota on drug metabolism and toxicity
-
Li, H., He, J. & Jia, W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin. Drug Metab. Toxicol. 12, 31-40 (2016).
-
(2016)
Expert Opin. Drug Metab. Toxicol.
, vol.12
, pp. 31-40
-
-
Li, H.1
He, J.2
Jia, W.3
-
15
-
-
0014387321
-
Drug metabolism by intestinal microorganisms
-
Scheline, R. R. Drug metabolism by intestinal microorganisms. J. Pharm. Sci. 57, 2021-2037 (1968).
-
(1968)
J. Pharm. Sci.
, vol.57
, pp. 2021-2037
-
-
Scheline, R.R.1
-
16
-
-
0019825594
-
Urinary excretion of reduced metabolites of digoxin
-
Lindenbaum, J., Tse-Eng, D., Butler, V. P. Jr & Rund, D. G. Urinary excretion of reduced metabolites of digoxin. Am. J. Med. 71, 67-74 (1981).
-
(1981)
Am. J. Med.
, vol.71
, pp. 67-74
-
-
Lindenbaum, J.1
Tse-Eng, D.2
Butler, V.P.3
Rund, D.G.4
-
17
-
-
84898016390
-
The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats
-
Lin, X. B. et al. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS ONE 9, e83644 (2014).
-
(2014)
PLoS ONE
, vol.9
, pp. e83644
-
-
Lin, X.B.1
-
18
-
-
38849190556
-
Gut microbiota: A potential new territory for drug targeting
-
Jia, W., Li, H., Zhao, L. & Nicholson, J. K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7, 123-129 (2008).
-
(2008)
Nat. Rev. Drug Discov.
, vol.7
, pp. 123-129
-
-
Jia, W.1
Li, H.2
Zhao, L.3
Nicholson, J.K.4
-
19
-
-
79952757721
-
Composition, variability, and temporal stability of the intestinal microbiota of the elderly
-
Claesson, M. J. et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4586-4591 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 4586-4591
-
-
Claesson, M.J.1
-
20
-
-
84953336403
-
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: A literature review and modelling study
-
Teillant, A., Gandra, S., Barter, D., Morgan, D. J. & Laxminarayan, R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect. Dis. 15, 1429-1437 (2015).
-
(2015)
Lancet Infect. Dis.
, vol.15
, pp. 1429-1437
-
-
Teillant, A.1
Gandra, S.2
Barter, D.3
Morgan, D.J.4
Laxminarayan, R.5
-
21
-
-
84886584256
-
Leukemia and risk of recurrent Escherichia coli bacteremia: Genotyping implicates E. Coli translocation from the colon to the bloodstream
-
Samet, A. et al. Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. Eur. J. Clin. Microbiol. Infect. Dis. 32, 1393-1400 (2013).
-
(2013)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.32
, pp. 1393-1400
-
-
Samet, A.1
-
22
-
-
0013954812
-
Translocation of microorganisms across the intestinal wall of the rat: Effect of microbial size and concentration
-
Wolochow, H., Hildebrand, G. J. & Lamanna, C. Translocation of microorganisms across the intestinal wall of the rat: effect of microbial size and concentration. J. Infect. Dis. 116, 523-528 (1966).
-
(1966)
J. Infect. Dis.
, vol.116
, pp. 523-528
-
-
Wolochow, H.1
Hildebrand, G.J.2
Lamanna, C.3
-
23
-
-
84875552922
-
Immunogenic cell death in cancer therapy
-
Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51-72 (2013).
-
(2013)
Annu. Rev. Immunol.
, vol.31
, pp. 51-72
-
-
Kroemer, G.1
Galluzzi, L.2
Kepp, O.3
Zitvogel, L.4
-
24
-
-
79551523389
-
Cyclophosphamide synergizes with type i interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis
-
Schiavoni, G. et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Res. 71, 768-778 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 768-778
-
-
Schiavoni, G.1
-
25
-
-
79551514818
-
Cyclophosphamide induces differentiation of Th17 cells in cancer patients
-
Viaud, S. et al. Cyclophosphamide induces differentiation of Th17 cells in cancer patients. Cancer Res. 71, 661-665 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 661-665
-
-
Viaud, S.1
-
26
-
-
84888059687
-
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide
-
This paper demonstrates that translocation of bacteria and stimulation of type 17 and type 1 T-helper cell responses is necessary for cyclophosphamide efficacy in tumour-bearing mice
-
Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976 (2013). This paper demonstrates that translocation of bacteria and stimulation of type 17 and type 1 T-helper cell responses is necessary for cyclophosphamide efficacy in tumour-bearing mice.
-
(2013)
Science
, vol.342
, pp. 971-976
-
-
Viaud, S.1
-
27
-
-
84994831796
-
Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects
-
Daillere, R. et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45, 931-943 (2016).
-
(2016)
Immunity
, vol.45
, pp. 931-943
-
-
Daillere, R.1
-
28
-
-
84888049920
-
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment
-
Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967-970 (2013)
-
(2013)
Science
, vol.342
, pp. 967-970
-
-
Iida, N.1
-
29
-
-
84948461699
-
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
-
Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084 (2015).
-
(2015)
Science
, vol.350
, pp. 1079-1084
-
-
Vetizou, M.1
-
30
-
-
84923335913
-
Cancer: Antitumour immunity gets a boost
-
Wolchok, J. D. & Chan, T. A. Cancer: antitumour immunity gets a boost. Nature 515, 496-498 (2014).
-
(2014)
Nature
, vol.515
, pp. 496-498
-
-
Wolchok, J.D.1
Chan, T.A.2
-
31
-
-
84948451779
-
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
-
Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089 (2015).
-
(2015)
Science
, vol.350
, pp. 1084-1089
-
-
Sivan, A.1
-
32
-
-
78650428877
-
Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma
-
Berman, D. et al. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun. 10, 11 (2010).
-
(2010)
Cancer Immun.
, vol.10
, pp. 11
-
-
Berman, D.1
-
33
-
-
84957565779
-
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockadeinduced colitis
-
Dubin, K. et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockadeinduced colitis. Nat. Commun. 7, 10391 (2016).
-
(2016)
Nat. Commun.
, vol.7
, pp. 10391
-
-
Dubin, K.1
-
34
-
-
0035424901
-
Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide
-
Abreu, M. T. et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167, 1609-1616 (2001).
-
(2001)
J. Immunol.
, vol.167
, pp. 1609-1616
-
-
Abreu, M.T.1
-
35
-
-
0034445697
-
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
-
Cario, E. & Podolsky, D. K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017 (2000).
-
(2000)
Infect. Immun.
, vol.68
, pp. 7010-7017
-
-
Cario, E.1
Podolsky, D.K.2
-
36
-
-
84922572991
-
TLR signaling modulates side effects of anticancer therapy in the small intestine
-
Frank, M. et al. TLR signaling modulates side effects of anticancer therapy in the small intestine. J. Immunol. 194, 1983-1995 (2015).
-
(2015)
J. Immunol.
, vol.194
, pp. 1983-1995
-
-
Frank, M.1
-
37
-
-
84971578038
-
Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms
-
Wardill, H. R. et al. Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Mol. Cancer Ther. 15, 1376-1386 (2016).
-
(2016)
Mol. Cancer Ther.
, vol.15
, pp. 1376-1386
-
-
Wardill, H.R.1
-
38
-
-
84904066463
-
Review of therapeutic drug monitoring of anticancer drugs part 1-cytotoxics
-
Paci, A. et al. Review of therapeutic drug monitoring of anticancer drugs part 1-cytotoxics. Eur. J. Cancer 50, 2010-2019 (2014).
-
(2014)
Eur. J. Cancer
, vol.50
, pp. 2010-2019
-
-
Paci, A.1
-
39
-
-
84928496512
-
Mucositis: Pathobiology and management
-
Villa, A. & Sonis, S. T. Mucositis: pathobiology and management. Curr. Opin. Oncol. 27, 159-164 (2015).
-
(2015)
Curr. Opin. Oncol.
, vol.27
, pp. 159-164
-
-
Villa, A.1
Sonis, S.T.2
-
40
-
-
84905858666
-
Systematic review: The role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications
-
Touchefeu, Y. et al. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 40, 409-421 (2014).
-
(2014)
Aliment. Pharmacol. Ther.
, vol.40
, pp. 409-421
-
-
Touchefeu, Y.1
-
41
-
-
33847389418
-
Updated clinical practice guidelines for the prevention and treatment of mucositis
-
Keefe, D. M. et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109, 820-831 (2007).
-
(2007)
Cancer
, vol.109
, pp. 820-831
-
-
Keefe, D.M.1
-
42
-
-
0035281522
-
Irinotecan in the treatment of colorectal cancer: Clinical overview
-
Vanhoefer, U. et al. Irinotecan in the treatment of colorectal cancer: clinical overview. J. Clin. Oncol. 19, 1501-1518 (2001).
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 1501-1518
-
-
Vanhoefer, U.1
-
43
-
-
84864386786
-
Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats
-
Lin, X. B. et al. Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS ONE 7, e39764 (2012).
-
(2012)
PLoS ONE
, vol.7
, pp. e39764
-
-
Lin, X.B.1
-
44
-
-
0028022585
-
Metabolic fate of irinotecan in humans: Correlation of glucuronidation with diarrhea
-
Gupta, E. et al. Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res. 54, 3723-3725 (1994).
-
(1994)
Cancer Res.
, vol.54
, pp. 3723-3725
-
-
Gupta, E.1
-
45
-
-
78149295964
-
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme
-
Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835 (2010).
-
(2010)
Science
, vol.330
, pp. 831-835
-
-
Wallace, B.D.1
-
46
-
-
84962744324
-
The inhibitory effect of ciprofloxacin on the beta-glucuronidase-mediated deconjugation of the irinotecan metabolite SN-38-G
-
Kodawara, T. et al. The inhibitory effect of ciprofloxacin on the beta-glucuronidase-mediated deconjugation of the irinotecan metabolite SN-38-G. Basic Clin. Pharmacol. Toxicol. 118, 333-337 (2016).
-
(2016)
Basic Clin. Pharmacol. Toxicol.
, vol.118
, pp. 333-337
-
-
Kodawara, T.1
-
47
-
-
84903837906
-
Old drug new use-amoxapine and its metabolites as potent bacterial beta-glucuronidase inhibitors for alleviating cancer drug toxicity
-
Kong, R. et al. Old drug new use-amoxapine and its metabolites as potent bacterial beta-glucuronidase inhibitors for alleviating cancer drug toxicity. Clin. Cancer Res. 20, 3521-3530 (2014).
-
(2014)
Clin. Cancer Res.
, vol.20
, pp. 3521-3530
-
-
Kong, R.1
-
48
-
-
84941938693
-
Structure and inhibition of microbiome beta-glucuronidases essential to the alleviation of cancer drug toxicity
-
Wallace, B. D. et al. Structure and inhibition of microbiome beta-glucuronidases essential to the alleviation of cancer drug toxicity. Chem. Biol. 22, 1238-1249 (2015).
-
(2015)
Chem. Biol.
, vol.22
, pp. 1238-1249
-
-
Wallace, B.D.1
-
49
-
-
77955898834
-
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity
-
Lam, W. et al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci. Transl Med. 2, 45ra59 (2010).
-
(2010)
Sci. Transl Med.
, vol.2
, pp. 45ra59
-
-
Lam, W.1
-
50
-
-
0030985696
-
Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil
-
Nakayama, H. et al. Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil. Pharmacogenetics 7, 35-43 (1997).
-
(1997)
Pharmacogenetics
, vol.7
, pp. 35-43
-
-
Nakayama, H.1
-
51
-
-
0031858786
-
Sorivudine and 5-fluorouracil; A clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase
-
Diasio, R. B. Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Br. J. Clin. Pharmacol. 46, 1-4 (1998).
-
(1998)
Br. J. Clin. Pharmacol.
, vol.46
, pp. 1-4
-
-
Diasio, R.B.1
-
52
-
-
0035032017
-
Mycoplasma infections and different human carcinomas
-
Huang, S., Li, J. Y., Wu, J., Meng, L. & Shou, C. C. Mycoplasma infections and different human carcinomas. World J. Gastroenterol. 7, 266-269 (2001).
-
(2001)
World J. Gastroenterol.
, vol.7
, pp. 266-269
-
-
Huang, S.1
Li, J.Y.2
Wu, J.3
Meng, L.4
Shou, C.C.5
-
53
-
-
45649084620
-
The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy
-
Bronckaers, A., Balzarini, J. & Liekens, S. The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: implications for cancer therapy. Biochem. Pharmacol. 76, 188-197 (2008).
-
(2008)
Biochem. Pharmacol.
, vol.76
, pp. 188-197
-
-
Bronckaers, A.1
Balzarini, J.2
Liekens, S.3
-
54
-
-
84900439025
-
Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine
-
Vande Voorde, J. et al. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J. Biol. Chem. 289, 13054-13065 (2014).
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 13054-13065
-
-
Vande Voorde, J.1
-
55
-
-
84938547773
-
Substantial decreases in the number and diversity of microbiota during chemotherapyinduced gastrointestinal mucositis in a rat model
-
Fijlstra, M. et al. Substantial decreases in the number and diversity of microbiota during chemotherapyinduced gastrointestinal mucositis in a rat model. Support. Care Cancer 23, 1513-1522 (2015).
-
(2015)
Support. Care Cancer
, vol.23
, pp. 1513-1522
-
-
Fijlstra, M.1
-
56
-
-
84909993511
-
16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during highdose chemotherapy as conditioning regimen for bone marrow transplantation
-
Montassier, E. et al. 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during highdose chemotherapy as conditioning regimen for bone marrow transplantation. Microb. Ecol. 67, 690-699 (2014).
-
(2014)
Microb. Ecol.
, vol.67
, pp. 690-699
-
-
Montassier, E.1
-
57
-
-
67651121491
-
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut
-
van Vliet, M. J. et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin. Infect. Dis. 49, 262-270 (2009).
-
(2009)
Clin. Infect. Dis.
, vol.49
, pp. 262-270
-
-
Van Vliet, M.J.1
-
58
-
-
84938555496
-
Chemotherapy-driven dysbiosis in the intestinal microbiome
-
Montassier, E. et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment. Pharmacol. Ther. 42, 515-528 (2015).
-
(2015)
Aliment. Pharmacol. Ther.
, vol.42
, pp. 515-528
-
-
Montassier, E.1
-
59
-
-
84903376660
-
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
-
Rooks, M. G. et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 8, 1403-1417 (2014).
-
(2014)
ISME J.
, vol.8
, pp. 1403-1417
-
-
Rooks, M.G.1
-
60
-
-
0003135066
-
The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus)
-
Coley, W. B. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc. R. Soc. Med. 3, 1-48 (1910).
-
(1910)
Proc. R. Soc. Med.
, vol.3
, pp. 1-48
-
-
Coley, W.B.1
-
61
-
-
84890120075
-
Defining progression in nonmuscle invasive bladder cancer: It is time for a new, standard definition
-
Lamm, D. et al. Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. J. Urol. 191, 20-27 (2014).
-
(2014)
J. Urol.
, vol.191
, pp. 20-27
-
-
Lamm, D.1
-
62
-
-
84869049715
-
Metabolic phenotyping in clinical and surgical environments
-
Nicholson, J. K. et al. Metabolic phenotyping in clinical and surgical environments. Nature 491, 384-392 (2012).
-
(2012)
Nature
, vol.491
, pp. 384-392
-
-
Nicholson, J.K.1
-
63
-
-
84940055522
-
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
-
Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973-1980 (2015).
-
(2015)
Gut
, vol.65
, pp. 1973-1980
-
-
Mima, K.1
-
64
-
-
84964514022
-
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection
-
Montassier, E. et al. Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med. 8, 49 (2016).
-
(2016)
Genome Med.
, vol.8
, pp. 49
-
-
Montassier, E.1
-
65
-
-
84977566637
-
The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia
-
Galloway-Pena, J. R. et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 122, 2186-2196 (2016).
-
(2016)
Cancer
, vol.122
, pp. 2186-2196
-
-
Galloway-Pena, J.R.1
-
66
-
-
84929094853
-
Fat, fibre and cancer risk in African Americans and rural Africans
-
OKeefe, S. J. et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).
-
(2015)
Nat. Commun.
, vol.6
, pp. 6342
-
-
Okeefe, S.J.1
-
67
-
-
79960300039
-
Bacterial translocation is reduced by a specific nutritional combination in mice with chemotherapy-induced neutropenia
-
Faber, J. et al. Bacterial translocation is reduced by a specific nutritional combination in mice with chemotherapy-induced neutropenia. J. Nutr. 141, 1292-1298 (2011).
-
(2011)
J. Nutr.
, vol.141
, pp. 1292-1298
-
-
Faber, J.1
-
68
-
-
84984601511
-
Fasting and caloric restriction in cancer prevention and treatment
-
Brandhorst, S. & Longo, V. D. Fasting and caloric restriction in cancer prevention and treatment. Recent Results Cancer Res. 207, 241-266 (2016).
-
(2016)
Recent Results Cancer Res.
, vol.207
, pp. 241-266
-
-
Brandhorst, S.1
Longo, V.D.2
-
69
-
-
84863229916
-
Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy
-
Lee, C. et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci. Transl Med. 4, 124ra27 (2012).
-
(2012)
Sci. Transl Med.
, vol.4
, pp. 124ra27
-
-
Lee, C.1
-
70
-
-
84948676244
-
Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: The role of SIRT1
-
Lee, J. D. et al. Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: the role of SIRT1. Eur. J. Cancer Prev. 25, 54-64 (2016).
-
(2016)
Eur. J. Cancer Prev.
, vol.25
, pp. 54-64
-
-
Lee, J.D.1
-
71
-
-
33847323097
-
Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia
-
Narta, U. K., Kanwar, S. S. & Azmi, W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit. Rev. Oncol. Hematol. 61, 208-221 (2007).
-
(2007)
Crit. Rev. Oncol. Hematol.
, vol.61
, pp. 208-221
-
-
Narta, U.K.1
Kanwar, S.S.2
Azmi, W.3
-
72
-
-
84994028116
-
Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo
-
Jeon, H. et al. Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo. Oncotarget 7, 67223-67234 (2016).
-
(2016)
Oncotarget
, vol.7
, pp. 67223-67234
-
-
Jeon, H.1
-
73
-
-
84872905650
-
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
-
Maddocks, O. D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542-546 (2013).
-
(2013)
Nature
, vol.493
, pp. 542-546
-
-
Maddocks, O.D.1
-
74
-
-
0031456990
-
Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo
-
Fu, Y. M., Yu, Z. X., Ferrans, V. J. & Meadows, G. G. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo. Nutr. Cancer 29, 104-113 (1997).
-
(1997)
Nutr. Cancer
, vol.29
, pp. 104-113
-
-
Fu, Y.M.1
Yu, Z.X.2
Ferrans, V.J.3
Meadows, G.G.4
-
75
-
-
84901625233
-
Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
-
Champ, C. E. et al. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J. Neurooncol. 117, 125-131 (2014).
-
(2014)
J. Neurooncol.
, vol.117
, pp. 125-131
-
-
Champ, C.E.1
-
76
-
-
84925851513
-
Fasting reduces the incidence of delayed-type vomiting associated with doxorubicin treatment in dogs with lymphoma
-
Withers, S. S. et al. Fasting reduces the incidence of delayed-type vomiting associated with doxorubicin treatment in dogs with lymphoma. Transl Oncol. 7, 377-383 (2014).
-
(2014)
Transl Oncol.
, vol.7
, pp. 377-383
-
-
Withers, S.S.1
-
77
-
-
84943789828
-
Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice
-
Huisman, S. A. et al. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice. Cell Cycle 14, 2333-2339 (2015).
-
(2015)
Cell Cycle
, vol.14
, pp. 2333-2339
-
-
Huisman, S.A.1
-
78
-
-
0035240033
-
Panax ginseng-a non-organ-specific cancer preventive?
-
Yun, T. K. Panax ginseng-a non-organ-specific cancer preventive? Lancet Oncol. 2, 49-55 (2001).
-
(2001)
Lancet Oncol.
, vol.2
, pp. 49-55
-
-
Yun, T.K.1
-
79
-
-
84921858255
-
Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer
-
Wang, C. Z. et al. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer. Nutrients 7, 799-814 (2015).
-
(2015)
Nutrients
, vol.7
, pp. 799-814
-
-
Wang, C.Z.1
-
80
-
-
34247332195
-
Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells
-
Wang, C. Z. et al. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother. Pharmacol. 60, 69-79 (2007).
-
(2007)
Cancer Chemother. Pharmacol.
, vol.60
, pp. 69-79
-
-
Wang, C.Z.1
-
81
-
-
69049106403
-
Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells
-
Li, X. L. et al. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother. Pharmacol. 64, 1097-1104 (2009).
-
(2009)
Cancer Chemother. Pharmacol.
, vol.64
, pp. 1097-1104
-
-
Li, X.L.1
-
82
-
-
84905049318
-
Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species
-
Selma, M. V., Beltran, D., Garcia-Villalba, R., Espin, J. C. & Tomas-Barberan, F. A. Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct. 5, 1779-1784 (2014).
-
(2014)
Food Funct.
, vol.5
, pp. 1779-1784
-
-
Selma, M.V.1
Beltran, D.2
Garcia-Villalba, R.3
Espin, J.C.4
Tomas-Barberan, F.A.5
-
83
-
-
84903906709
-
Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells
-
Gonzalez-Sarrias, A. et al. Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. Eur. J. Nutr. 53, 853-864 (2014).
-
(2014)
Eur. J. Nutr.
, vol.53
, pp. 853-864
-
-
Gonzalez-Sarrias, A.1
-
84
-
-
84929485270
-
The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells
-
Gonzalez-Sarrias, A., Tome-Carneiro, J., Bellesia, A., Tomas-Barberan, F. A. & Espin, J. C. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food Funct. 6, 1460-1469 (2015).
-
(2015)
Food Funct.
, vol.6
, pp. 1460-1469
-
-
Gonzalez-Sarrias, A.1
Tome-Carneiro, J.2
Bellesia, A.3
Tomas-Barberan, F.A.4
Espin, J.C.5
-
85
-
-
84907856427
-
Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy
-
Tang, Q. et al. Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy. Food Funct. 5, 2529-2535 (2014).
-
(2014)
Food Funct.
, vol.5
, pp. 2529-2535
-
-
Tang, Q.1
-
86
-
-
84928590068
-
The efficacy and safety of probiotics in people with cancer: A systematic review
-
Redman, M. G., Ward, E. J. & Phillips, R. S. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann. Oncol. 25, 1919-1929 (2014).
-
(2014)
Ann. Oncol.
, vol.25
, pp. 1919-1929
-
-
Redman, M.G.1
Ward, E.J.2
Phillips, R.S.3
-
87
-
-
42549126844
-
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
-
Bowen, J. M. et al. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol. Ther. 6, 1449-1454 (2007).
-
(2007)
Cancer Biol. Ther.
, vol.6
, pp. 1449-1454
-
-
Bowen, J.M.1
-
88
-
-
33847229128
-
Probiotic effects on 5-fluorouracilinduced mucositis assessed by the sucrose breath test in rats
-
Mauger, C. A., Butler, R. N., Geier, M. S., Tooley, K. L. & Howarth, G. S. Probiotic effects on 5-fluorouracilinduced mucositis assessed by the sucrose breath test in rats. Dig. Dis. Sci. 52, 612-619 (2007).
-
(2007)
Dig. Dis. Sci.
, vol.52
, pp. 612-619
-
-
Mauger, C.A.1
Butler, R.N.2
Geier, M.S.3
Tooley, K.L.4
Howarth, G.S.5
-
89
-
-
84947762368
-
Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model
-
Yeung, C. Y. et al. Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PLoS ONE 10, e0138746 (2015).
-
(2015)
PLoS ONE
, vol.10
, pp. e0138746
-
-
Yeung, C.Y.1
-
90
-
-
35348904439
-
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: A randomised study
-
Osterlund, P. et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br. J. Cancer 97, 1028-1034 (2007).
-
(2007)
Br. J. Cancer
, vol.97
, pp. 1028-1034
-
-
Osterlund, P.1
-
91
-
-
84948800191
-
Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients
-
Motoori, M. et al. Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients. Clin. Nutr. 36, 93-99 (2017).
-
Clin. Nutr.
, vol.36
, Issue.93-99
, pp. 2017
-
-
Motoori, M.1
-
92
-
-
77953610750
-
Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
-
Wada, M. et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support. Care Cancer 18, 751-759 (2010).
-
(2010)
Support. Care Cancer
, vol.18
, pp. 751-759
-
-
Wada, M.1
-
93
-
-
32644459142
-
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74
-
Mego, M. et al. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support. Care Cancer 14, 285-290 (2006).
-
(2006)
Phase II Study. Support. Care Cancer
, vol.14
, pp. 285-290
-
-
Mego, M.1
-
94
-
-
16244394837
-
Possible adjuvant cancer therapy by two prebiotics-inulin or oligofructose
-
Taper, H. S. & Roberfroid, M. B. Possible adjuvant cancer therapy by two prebiotics-inulin or oligofructose. In Vivo 19, 201-204 (2005).
-
(2005)
In Vivo
, vol.19
, pp. 201-204
-
-
Taper, H.S.1
Roberfroid, M.B.2
-
95
-
-
0034448768
-
Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin
-
Taper, H. S. & Roberfroid, M. B. Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin. Nutr. Cancer 38, 1-5 (2000).
-
(2000)
Nutr. Cancer
, vol.38
, pp. 1-5
-
-
Taper, H.S.1
Roberfroid, M.B.2
-
96
-
-
84876539160
-
An inulin and doxorubicin conjugate for improving cancer therapy
-
Schoener, C. A., Carillo-Conde, B., Hutson, H. N. & Peppas, N. A. An inulin and doxorubicin conjugate for improving cancer therapy. J. Drug Deliv. Sci. Technol. 23, 111-118 (2013).
-
(2013)
J. Drug Deliv. Sci. Technol.
, vol.23
, pp. 111-118
-
-
Schoener, C.A.1
Carillo-Conde, B.2
Hutson, H.N.3
Peppas, N.A.4
-
97
-
-
84885629462
-
Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics
-
Kim, J. S. et al. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics. Support. Care Cancer 21, 3103-3107 (2013).
-
(2013)
Support. Care Cancer
, vol.21
, pp. 3103-3107
-
-
Kim, J.S.1
-
98
-
-
0034682335
-
Lateral gene transfer and the nature of bacterial innovation
-
Ochman, H., Lawrence, J. G. & Groisman, E. A. Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299-304 (2000).
-
(2000)
Nature
, vol.405
, pp. 299-304
-
-
Ochman, H.1
Lawrence, J.G.2
Groisman, E.A.3
-
99
-
-
84992070829
-
Enhanced TLR4 expression on colon cancer cells after chemotherapy promotes cell survival and epithelial-mesenchymal transition through phosphorylation of GSK3beta
-
Chung, Y. H. & Kim, D. Enhanced TLR4 expression on colon cancer cells after chemotherapy promotes cell survival and epithelial-mesenchymal transition through phosphorylation of GSK3beta. Anticancer Res. 36, 3383-3394 (2016).
-
(2016)
Anticancer Res.
, vol.36
, pp. 3383-3394
-
-
Chung, Y.H.1
Kim, D.2
-
100
-
-
84856969539
-
Fecal microbiota transplantation and emerging applications
-
Borody, T. J. & Khoruts, A. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88-96 (2011).
-
(2011)
Nat. Rev. Gastroenterol. Hepatol.
, vol.9
, pp. 88-96
-
-
Borody, T.J.1
Khoruts, A.2
-
101
-
-
84873038467
-
Fecal microbiota transplantation-an old therapy comes of age
-
Kelly, C. P. Fecal microbiota transplantation-an old therapy comes of age. N. Engl. J. Med. 368, 474-475 (2013).
-
(2013)
N. Engl. J. Med.
, vol.368
, pp. 474-475
-
-
Kelly, C.P.1
-
102
-
-
85020615240
-
Seress pioneering microbiome drug fails midstage trial
-
Ratner, M. Seress pioneering microbiome drug fails midstage trial. Nat. Biotechnol. 34, 1004-1005 (2016).
-
(2016)
Nat. Biotechnol.
, vol.34
, pp. 1004-1005
-
-
Ratner, M.1
-
103
-
-
84894241861
-
Policy: How to regulate faecal transplants
-
Smith, M. B., Kelly, C. & Alm, E. J. Policy: How to regulate faecal transplants. Nature 506, 290-291 (2014).
-
(2014)
Nature
, vol.506
, pp. 290-291
-
-
Smith, M.B.1
Kelly, C.2
Alm, E.J.3
-
104
-
-
84856456056
-
E. Coli-produced BMP-2 as a chemopreventive strategy for colon cancer: A proof-of-concept study
-
Yuvaraj, S. et al. E. coli-produced BMP-2 as a chemopreventive strategy for colon cancer: a proof-of-concept study. Gastroenterol. Res. Pract. 2012, 895462 (2012).
-
(2012)
Gastroenterol. Res. Pract.
, vol.2012
, pp. 895462
-
-
Yuvaraj, S.1
-
105
-
-
84982836605
-
Synchronized cycles of bacterial lysis for in vivo delivery
-
Din, M. O. et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature 536, 81-85 (2016).
-
(2016)
Nature
, vol.536
, pp. 81-85
-
-
Din, M.O.1
-
106
-
-
78651061453
-
Streptomycin alleviates irinotecaninduced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen
-
Kurita, A. et al. Streptomycin alleviates irinotecaninduced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemother. Pharmacol. 67, 201-213 (2011).
-
(2011)
Cancer Chemother. Pharmacol.
, vol.67
, pp. 201-213
-
-
Kurita, A.1
|